Line 747: |
Line 747: |
| | | | | |
| | | | | |
− | | | + | |Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 |
| |Tracy Tucker, PhD, FCCMG | | |Tracy Tucker, PhD, FCCMG |
| | | | | |
Line 763: |
Line 763: |
| | | | | |
| | | | | |
− | | | + | |Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged |
| |Tracy Tucker, PhD, FCCMG | | |Tracy Tucker, PhD, FCCMG |
| | | | | |
Line 779: |
Line 779: |
| | | | | |
| | | | | |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]] | | |[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]] |
Line 795: |
Line 795: |
| | | | | |
| | | | | |
− | | | + | |Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified |
| |Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | | |Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD |
| | | | | |
Line 811: |
Line 811: |
| | | | | |
| | | | | |
− | | | + | |Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified |
| |Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | | |Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine |
| | | | | |
Line 827: |
Line 827: |
| | | | | |
| | | | | |
− | | | + | |Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types |
| |Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | | |Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina |
| | | | | |
Line 843: |
Line 843: |
| | | | | |
| | | | | |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]] | | |[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]] |
Line 859: |
Line 859: |
| | | | | |
| | | | | |
− | | | + | |Acute Undifferentiated Leukemia |
| |Amelia Nakanishi, MD and Shashi Shetty, PhD | | |Amelia Nakanishi, MD and Shashi Shetty, PhD |
| | | | | |